Pay in 4 interest-free payments of $6.07 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Abstract CT214: Preliminary efficacy of telisotuzumab vedotin (Teliso-V) treatment in the 2L/3L setting in MET gene amplified (MET Amp), c-Met protein overexpressing (c-Met OE), non-squamous, non-small cell lung cancer (NSQ NSCLC): retrospective analysis of LUMINOSITY
You can find them all at our office or our online store
Acknowledgements This work was funded by grants from the Yunnan University Medical Research Foundation Department of Radiology (Grant No
10.1038/s41467-025-60844-9 8 BoutouyrieP.ChowienczykP.HumphreyJ
:max_bytes(150000):strip_icc()/GettyImages-1299286851-18ab6e02931940ad963dda93851b6dc7.jpg)
SQ 26,180, a novel monobactam
US$ 25.94
US$ 24.91
US$ 27.18
US$ 26.69
